Researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine are part of an international team of scientists who identified mechanisms by which some multiple myelomas become resistant to initially effective T-cell therapies.
Frank J. Penedo, associate director for cancer survivorship and translational behavioral sciences at Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine, is the recipient of the International Society of Behavioral Medicine’s 2023 ISBM Distinguished Scientist Award. The award was presented at the 17th Congress of the ISBM in Vancouver, British Columbia, and recognizes distinguished theoretical or empirical contributions to behavioral medicine.
Jashodeep Datta, a researcher with Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, has been awarded a grant from the U.S. Department of Defense’s Congressionally Directed Medical Research Program to target chemotherapy resistance in pancreatic cancer. The $800,000, three-year grant is the first DoD award to Sylvester to study pancreatic cancer.
Researchers from Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine and Dana Farber Cancer Institute have received $7 million from the Patient-Centered Outcomes Research Institute to study how diet and exercise impact mental and physical functioning in older cancer survivors and their caregivers.
The Diversity in Cancer Research Internship Program, part of the University of Miami Miller School of Medicine, was established to give undergraduate college students from under-represented communities exposure and experience in the hopes of increasing diversity among cancer researchers.
Researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine have developed an orally administered drug to disrupt prostate cancer cells’ metabolism and deliver the chemotherapy agent cisplatin directly into treatment-resistant prostate cancer cells.
A large-scale retrospective analysis by researchers with the Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine suggests that differences in care, rather than genetics, likely explain disparities in advanced prostate cancer between men of African and European ancestry.
Researchers with the Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine and collaborators have shown that immature natural killer cells are present in patients with triple-negative breast cancer and likely promote, instead of inhibit, disease progression in this cancer type.
Investigators at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine found that treatment outcomes for patients with malignant pleural mesothelioma, a rare cancer commonly known as mesothelioma, are often affected by social determinants of health and that overall survival rates could be improved by addressing these health disparities and improving access to specialized care.
Researchers have shown for the first time exactly how immature neutrophils—white blood cells that are an important part of the immune system—are hijacked by pancreatic cancers to drive immunosuppression and treatment resistance. The study, led by investigators at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, was published in Cancer Discovery.
